Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Medicine, Oncology, Chemotherapy, Cancer, Lung cancer, and Internal medicine.
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
Tarlatamab versus chemotherapy (CTx) as second-line (2L) treatment for small cell lung cancer (SCLC): Primary analysis of Ph3 DeLLphi-304.
LBA18 Trastuzumab deruxtecan (T-DXd) + pertuzumab (P) vs taxane + trastuzumab + pertuzumab (THP) for patients (pts) with HER2+ advanced/metastatic breast cancer (a/mBC): Additional analyses of DESTINY-Breast09 in key subgroups of interest
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study
Abemaciclib plus fulvestrant vs fulvestrant alone for HR+, HER2- advanced breast cancer following progression on a prior CDK4/6 inhibitor plus endocrine therapy: Primary outcome of the phase 3 postMONARCH trial.